Meningococcal Quadrivalent Vaccine

Trade Agreement: Agreement on Internal Trade (AIT)
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: 
Comprehensive Land Claim Agreement: No
Nature of Requirements: 

Requirement

To supply Meningococcal Quadrivalent vaccine on as and when requested basis to various Federal, Provincial and Territorial (F/P/T) consignees as part of the F/P/T Group Purchasing Program.

Quantiy

The estimated requirement is 315,270 for for firm year 2017-18 and 315,981 for firm year 2018-19.

Contract Period

April 1, 2017 to March 31, 2019 with the option to extend the contract period for one additional one year period from April 1, 2019  to March 31, 2020.

Delivery

Will be on as and when requested basis.

Trade Agreements

 The provisions of the WTO-AGP, NAFTA, Canada-Chile Free Trade 
Agreement (CCFTA) and Canada-Columbia Free Trade Agreement Canada- Peru 
Free Trade (FTA) are not applicable for reasons connected with the protection of human life and health (see NAFTA article 1018 para. 2 (b
); WTO-AGP article XXIII (2); CCFTA Article Kbis 16-2(b); and FTA article 2202 para. 2(b) ), and because of the absence of regulatory harmonization between Canada and the other signatory countries to the WTO, NAFTA CCFTA ,and FTA.

The provisions of the Agreement on Internal Trade (AIT) are applicable

Canada and PWGSC as Agent

This requirement is for the Federal/Provincial/Territorial(F/P/T) Group 
Purchasing Program for Drugs and Vaccines. Canada is acting as a purchasing agent for Provincial and Territorial Governments.

Inquiries regarding this RFP are to be submitted to the contracting officer listed below.

Delivery Date: 01/04/2017

The Crown retains the right to negotiate with suppliers on any procurement.

Documents may be submitted in either official language of Canada.